Gujarat Terce Labs.
Ticker > Company >

Gujarat Terce Labs. share price

Gujarat Terce Laboratories Ltd.

BSE: 524314 SECTOR: Pharmaceuticals & Drugs  15.06 K   13   0

34.50
+0.79 (2.34%)
BSE: Today, 11:07 AM

Price Summary

Today's High

₹ 35.79

Today's Low

₹ 33.53

52 Week High

₹ 59.78

52 Week Low

₹ 29

FinStar is Suspended!

The FinStar rating for this company is currently unavailable due to limited data disclosure. As a micro-cap company, it may carry higher risk and limited transparency. We will update the FinStar rating once more reliable data becomes available.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 26.88 Cr.

Enterprise Value

₹ 27.04 Cr.

No. of Shares

0.78 Cr.

P/E

12.21

P/B

2.76

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  12.49

CASH

₹ 0.78 Cr.

DEBT

₹ 0.94 Cr.

Promoter Holding

40.03 %

EPS (TTM)

₹  2.82

Sales Growth

4.63%

ROE

-14.79 %

ROCE

41.39%

Profit Growth

-501.93 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Gujarat Terce Laboratories Ltd.

Vitfol Acolate Resplash Aziter Codimol TerfloraZ Tynol fungibeat

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year4.63%
3 Year7.74%
5 Year5.98%

Profit Growth

1 Year-501.93%
3 Year-203.91%
5 Year-228.79%

ROE%

1 Year-14.79%
3 Year-11.01%
5 Year-9.82%

ROCE %

1 Year41.39%
3 Year12.1%
5 Year5.64%

Debt/Equity

0.1537

Price to Cash Flow

8.79

Interest Cover Ratio

9.1618

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2026 40.03 0.00
Mar 2026 40.03 0.00
Dec 2025 40.03 0.00
Sep 2025 37.03 0.00
Jun 2025 37.03 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has significantly decreased its debt by 2.9247 Cr.
  • Company has a healthy Interest coverage ratio of 9.1618.
  • The company has an efficient Cash Conversion Cycle of -20.5968 days.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 29.8685004396116.

 Limitations

  • The company has shown a poor profit growth of -203.91093163918% for the Past 3 years.
  • The company has shown a poor revenue growth of 7.74174516494512% for the Past 3 years.
  • Company has a poor ROE of -11.006% over the past 3 years.
  • The company has a low EBITDA margin of -0.490609591098196% over the past 5 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Net Sales 12.32 10.85 12.93 12.29 11.4
Total Expenditure 11.27 10.88 11.04 11.16 10.66
Operating Profit 1.05 -0.02 1.89 1.14 0.74
Other Income 0.09 0.1 0.06 0.13 0.08
Interest 0.07 0.05 0.07 0.04 0.03
Depreciation 0.1 0.1 0.1 0.1 0.13
Exceptional Items 0 0 0 0 -0.45
Profit Before Tax 0.97 -0.07 1.79 1.13 0.21
Tax 4.36 -0.03 0.38 0.37 0.1
Profit After Tax -3.39 -0.04 1.41 0.76 0.1
Adjusted EPS (Rs) -4.57 -0.06 1.89 0.98 0.13

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 25.18 40.13 46.78 47.97 50.2
Total Expenditure 27.95 39.02 48.95 46.71 46.31
Operating Profit -2.77 1.12 -2.16 1.27 3.88
Other Income 0.8 0.31 0.35 0.32 0.31
Interest 0.39 0.4 0.72 0.68 0.42
Depreciation 0.18 0.28 0.36 0.37 0.38
Exceptional Items 0 0 0 0 0
Profit Before Tax -2.53 0.75 -2.89 0.54 3.39
Tax -0.01 -0.13 -1.22 0.3 4.37
Net Profit -2.52 0.87 -1.67 0.24 -0.98
Adjusted EPS (Rs.) -3.4 1.18 -2.25 0.33 -1.32

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 7.42 7.42 7.42 7.42 7.42
Total Reserves 0.24 1.11 -0.56 -0.31 -0.94
Borrowings 0.42 2.3 1.46 0.93 0.3
Other N/C liabilities 1.9 3.04 2.07 1.88 2.98
Current liabilities 11.71 13.21 16.61 12.14 12.64
Total Liabilities 21.7 27.09 27 22.05 22.39
Assets
Net Block 2.45 4.29 3.99 3.69 3.65
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0.27 0.27 0.27 0.27 0
Loans & Advances 2.55 2.65 2.29 2.46 2.31
Other N/C Assets 4.4 4.4 4.4 4.4 4.4
Current Assets 12.02 15.48 16.05 11.22 12.02
Total Assets 21.7 27.09 27 22.05 22.39
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations -2.52 0.75 -2.89 0.54 3.39
Adjustment 0.57 0.6 1.02 0.76 0.53
Changes in Assets & Liabilities 1.94 -1.69 1.94 1.29 -0.78
Tax Paid -0.15 -0.1 -0.04 0 -0.08
Operating Cash Flow -0.16 -0.44 0.03 2.6 3.06
Investing Cash Flow -0.42 -2.37 0.62 -0.46 0.46
Financing Cash Flow 1.83 1.53 -0.12 -4.08 -2.83
Net Cash Flow 1.24 -1.28 0.52 -1.94 0.69

Corporate Actions

Investors Details

PARTICULARS Jun 2025% Sep 2025% Dec 2025% Mar 2026% Jun 2026%
promoters 37.03 37.03 40.03 40.03 40.03
aalap natubhai prajapati 13.22 13.22 17.35 17.35 17.35
abundant trade link priva... 14.50 14.50 - 13.81 13.81
amritbhai p. prajapati 0.42 0.42 0.40 0.40 0.40
natwarbhai parsottam praj... 8.57 8.57 8.16 8.16 8.16
shachi ravi oza 0.10 0.10 0.10 0.10 0.10
shobhanaben natvarbhai pr... 0.22 0.22 0.21 0.21 0.21
abundant trade link priv... - - 13.81 - -
PARTICULARS Mar 2025% Sep 2025% Dec 2025% Mar 2026% Jun 2026%
investors 62.97 62.97 59.97 59.97 59.97
dheeraj kumar lohia 1.21 1.21 1.04 1.04 1.04
ganesh vetrivel periasamy... - - 1.20 1.24 1.25
rishabh negi 1.01 1.01 - - 1.01
sagar saxena 1.39 1.39 1.35 1.35 1.35
l7 hitech private limited... - 1.01 - - -

Annual Reports

Title Link
Title Link
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY26
Presentation Q3FY26
Presentation Q3FY24
Presentation Q3FY22
Presentation Q2FY22
Presentation Q1FY25

Company News

Guj. Terce Lab - Quaterly Results 5 Feb, 12:00 AM Gujarat Terce Laboratories informs about updates 17 Dec, 5:23 PM Guj. Terce Lab - Quaterly Results 9 Nov, 12:00 AM Gujarat Terce Laboratories informs about updates 21 Aug, 3:25 PM Guj. Terce Lab - Quaterly Results 11 Aug, 4:35 PM Guj. Terce Lab - Quaterly Results 11 Aug, 4:35 PM Guj. Terce Lab - Quaterly Results 11 Aug, 4:35 PM Guj. Terce Lab - Quaterly Results 26 May, 8:58 PM Guj. Terce Lab - Quaterly Results 26 May, 8:58 PM Gujarat Terce Laboratories informs about closure of trading window 25 Mar, 12:44 PM Guj. Terce Lab - Quaterly Results 4 Feb, 4:59 PM Guj. Terce Lab - Quaterly Results 4 Feb, 4:59 PM Guj. Terce Lab - Quaterly Results 4 Feb, 4:59 PM Gujarat Terce Laboratories informs about board meeting 27 Jan, 12:55 PM Gujarat Terce Laboratories informs about disclosure 21 Nov, 11:19 AM Gujarat Terce Laboratories informs about disclosure 30 Oct, 5:36 PM Gujarat Terce Laboratories informs about disclosures 30 Oct, 5:34 PM Gujarat Terce Laboratories informs about disclosures 30 Oct, 5:27 PM Guj. Terce Lab - Quaterly Results 30 Oct, 3:16 PM Guj. Terce Lab - Quaterly Results 30 Oct, 3:16 PM Gujarat Terce Laboratories informs about board meeting 18 Oct, 11:04 AM GujaratTerce Laboratories informs about closure of trading window 26 Sep, 9:51 AM Gujarat Terce Laboratories informs about press release 31 Aug, 12:15 PM Gujarat Terce Laboratories informs about annual report 24 Aug, 3:20 PM Gujarat Terce Laboratories informs about annual report 24 Aug, 12:29 PM Gujarat Terce Laboratories informs about issuance of duplicate share certificate 21 Aug, 9:43 AM Guj. Terce Lab - Quaterly Results 9 Aug, 5:22 PM Guj. Terce Lab - Quaterly Results 9 Aug, 5:22 PM Guj. Terce Lab - Quaterly Results 9 Aug, 5:22 PM Gujarat Terce Laboratories informs about certificate 8 Jul, 11:11 AM Guj. Terce Lab - Quaterly Results 5 Feb, 4:51 PM Guj. Terce Lab - Quaterly Results 5 Feb, 4:51 PM Guj. Terce Lab - Quaterly Results 5 Feb, 4:51 PM Gujarat Terce Laboratories informs about loss of share certificate 5 Jan, 4:10 PM Gujarat Terce Laboratories informs about loss of share certificate 3 Jun, 3:58 PM Guj. Terce Lab - Quaterly Results 13 May, 7:17 PM Guj. Terce Lab - Quaterly Results 13 May, 7:17 PM Guj. Terce Lab - Quaterly Results 31 Jan, 5:40 PM Guj. Terce Lab - Quaterly Results 31 Jan, 5:40 PM Guj. Terce Lab - Quaterly Results 31 Jan, 5:40 PM Gujarat Terce Laboratories informs about RPT disclosure 25 Nov, 5:08 PM Gujarat Terce Laboratories informs about resignation of CS cum CO 6 Sep, 5:04 PM Guj. Terce Lab - Quaterly Results 5 Aug, 5:18 PM Guj. Terce Lab - Quaterly Results 5 Aug, 5:18 PM Guj. Terce Lab - Quaterly Results 5 Aug, 5:18 PM Gujarat Terce Laboratories informs about board meeting 27 Jul, 12:22 PM Gujarat Terce Laboratories informs about compliance certificate 7 Jul, 4:50 PM Gujarat Terce Laboratories informs about compliance certificate 14 Apr, 10:39 AM Gujarat Terce Laboratories informs about outcome of board meeting 24 Jan, 2:47 PM Guj. Terce Lab - Quaterly Results 24 Jan, 12:23 PM

Gujarat Terce Labs. Stock Price Analysis and Quick Research Report. Is Gujarat Terce Labs. an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Gujarat Terce Labs.. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Gujarat Terce Labs. has a PE ratio of 12.2128216928033 which is low and comparatively undervalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Gujarat Terce Labs. has ROA of -4.4041% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Gujarat Terce Labs. has a Current ratio of 0.9511.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Gujarat Terce Labs. has a ROE of -14.791%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Gujarat Terce Labs. has a Debt to Equity ratio of 0.1537 which means that the company has low proportion of debt in its capital.

  • Sales growth: Gujarat Terce Labs. has reported revenue growth of 4.6285% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Gujarat Terce Labs. for the current financial year is 7.73500255004463%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Gujarat Terce Labs. is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Gujarat Terce Labs. is Rs 2.8249. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Gujarat Terce Labs. in Ticker for free. Also, one can get the intrinsic value of Gujarat Terce Labs. by using Valuation Calculators, which are available with a Finology ONE subscription. 

Gujarat Terce Labs. FAQs

Q1. What is Gujarat Terce Labs. share price today?
Ans: The current share price of Gujarat Terce Labs. is Rs 34.5.

Q2. What is the market capitalisation of Gujarat Terce Labs.?
Ans: Gujarat Terce Labs. has a market capitalisation of Rs 26.879985 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Gujarat Terce Labs.?
Ans: The PE ratio of Gujarat Terce Labs. is 12.2128216928033 and the P/B ratio of Gujarat Terce Labs. is 2.76307253666077, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Gujarat Terce Labs. share?
Ans: The 52-week high share price of Gujarat Terce Labs. is Rs 59.78, and the 52-week low share price of Gujarat Terce Labs. is Rs 29.

Q5. Does Gujarat Terce Labs. pay dividends?
Ans: Currently, Gujarat Terce Labs. does not pay dividends. Dividend yield of Gujarat Terce Labs. is around 0%.

Q6. What are the face value and book value of Gujarat Terce Labs. shares?
Ans: The face value of Gujarat Terce Labs. shares is Rs 10, while the book value per share of Gujarat Terce Labs. is around Rs 12.4861. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Gujarat Terce Labs.?
Ans: Gujarat Terce Labs. has a total debt of Rs 0.9418 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Gujarat Terce Labs.?
Ans: The ROE of Gujarat Terce Labs. is -14.791% and ROCE of Gujarat Terce Labs. is 41.3854%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Gujarat Terce Labs. a good buy for the long term?
Ans: The Gujarat Terce Labs. long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Gujarat Terce Labs. undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Gujarat Terce Labs. appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Gujarat Terce Labs.’s financials?
Ans: You can review Gujarat Terce Labs.’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Gujarat Terce Labs.
X